Skip to main content

Pharmaceutics Articles

academics

 

Clinical research courses

  • DEVELOPMENT, CHARACTERISATION AND INVITRO EVALUATION OF BUCCOADHESIVE BILAYERED TABLETS FOR THE TREATMENT OF HYPERTENSION

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Kavitha Reddy Jupally*, A.Pavani, R. Raja Reddy, Habibuddin.
    Department of Pharmaceutics, Malla Reddy Pharmacy College,
    Maisammaguda (via- Hakimpet), secunderabad, Telangana, India.
    kavithareddy0811@gmail.com

    ABSTRACT
    Ramipril is a prodrug belonging to the class of angiotensin-converting enzyme (ACE) inhibitor, which undergoes extensive hepatic first pass metabolism. The aim of the present study is to develop buccoadhesive bilayered tablet of ramipril  to achieve the greater therapeutic efficacy, to increase the bioavailability, to overcome the first pass hepatic metabolism of the drug. A UV spectrophotometric method has been employed for the estimation of Ramipril at 219 nm. Buccal tablets of Ramipril were prepared by direct compression method using ethyl cellulose as a polymer. The precompression parameters like bulk density, tapped density, carr’s index and angle of repose were determined. The post compression parameters like hardness, thickness, friability, weight variation, in vitro dissolution, FTIR studies were carried out to check if any interactions had occurred, results were promising. The optimized formulation was selected based on results and percentage drug release was found to be 92.95 and followed First order, peppas model with Fickian release mechanism.

  • A BRIEF REVIEW ON SUSTAINED RELEASE MATRIX TABLETS OF BACLOFEN

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Singh Surya Pratap*, Soni Shankar Lal, Khinchi Mahaveer Prasad, Gulia Ritu, Namdev Abhisek
    Department of pharmaceutics, Kota College of  Pharmacy,
    Ranpur, Kota, Rajasthan, India
    sp.kota91@gmail.com

    ABSTRACT
    The objective of the present study was to focus on sustained release matrix tablets of baclofen, for treatment of spastically resulting from multiple sclerosis, flexor spasm and muscular rigidity. Designing effective therapies for Spinal cord injury (SCI) has been a challenging problem because spinal cord injuries are heterogeneous in causality, severity and location of injury.
    Effective drug therapy for Spinal cord injury (SCI) first became a reality in 1990 with the finding that the steroid drug methylprednisolone(MP) can significantly improve recovery. Significant advances in recent year, including an effective drug therapy for acute SCI, have improve recovery. In spinal cord injury, pain persist for longer period i.e., several months, hence the long-term treatment is necessary for maintaining the drug concentration in the therapeutic range.
    Hence, there is a need of sustained release dosage form. Baclofen,4-amino-3-(4-chlorophenyl)-butyric acid is another structural analog of GABA, which is widely used now a days in the treatment of multiple sclerosis, flexor spasms, muscular rigidity. spinal cord injuries and other spinal cord diseases.

  • EFFECT OF MAGNETIC FIELD ON CANCER CELLS

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Rajesh Tiwari1*, Roshan kumar2
    1Chemistry Department, Dr. Ghanshyam Singh Post Graduate College, Varanasi
    2SBCBE VIT University, Vellore
    *Rajesh.tiwari851@gmail.com

    ABSTRACT
    In 16th century physician were of the opinion that magnet can be used for the treatment or eliminate the diseases from the body. Here the reports about the chemical synthesis, protection, functionalization and application of magnetic nanoparticles of nano structured system. Research of magnetic nanoparticles for targeted drug delivery system and function of magnetic nanoparticles on particular area are reviewed. Use of magnetic nanoparticles for cancer diagnosis has been advancing day by day. This review is related to the multifunctional use of magnetic nanoparticles probes and their use in bio imaging and nano medicine.

  • FORMULATION AND IN VITRO EVALUATION OF IBUPROFEN LOADED ETHYL CELLULOSE MICROSPHERES

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Lakshmanarao.R*, Pavani Priya.G, Saikishore.V
    Department of pharmaceutics,
    Bapatla college of pharmacy, Bapatla-522101, India
    rapakalakshmanarao@gmail.com

    ABSTRACT:
    Microspheres are well accepted technique to control the drug release from the dosage form to improve bioavailability, reduce absorption difference in patients, reduce the dosing frequency and adverse effects during prolong treatment. The main objective of the present study is to prepare and evaluate ibuprofen  microspheres by solvent evaporation  method, with water insoluble polymers such as Ethyl cellulose and sodium carboxymethyl cellulose as suspending agent, using as carrier for oral administration in view to achieve oral sustained  release of the drug.  Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used for relief of signs and symptoms of rheumatoid arthritis, osteoarthritis and is used in chronic and acute conditions of pain and inflammation. Its biological half-life is 2 ±0.5 hrs. Due to its low biological half-life (2 hrs), it requires frequent administration to maintain plasma concentration. This causes inconvenience to the patient and also leads fluctuations in plasma drug concentration that may cause inferior therapeutic effects or toxic effects. There-fore, development of controlled release dosage forms would clearly be beneficial in terms of decreased dosage requirements, thus increase patient compliance. The formulations were evaluated for particle size distribution analysis, flow properties like Angle of repose, bulk density, tapped density, Hausner’s Ratio, Carr’s index, Encapsulation efficiency, Scanning electron microscopy,optical electron microscopy and invitro release studies. The optimized formulation showed good invitro sustained  release activity of the drug ibuprofen.

  • TRANSDERMAL DRUG DELIVERY THROUGH CARRIERS: TRANSFERSOMES

    { DOWNLOAD AS PDF }

    ABOUT AUTHOR:
    Nirlep kaur
    Institute of pharmaceutical sciences,
    Kurukshetra University, Kurukshetra, Haryana, India
    Nirlep10@gmail.com

    ABSTRACT
    Delivery of drug through Transdermal route represents a most convenient and novel approach. Transfersomes were found to be more effective as they render controlled release of drug due to depot formation in skin and were more effective in transdermal delivery. Transfersomes are applied to the skin and permeate through the stratum corneum lipid lamellar regions as a result of the hydration and osmotic force in the skin. Transfersomes have been widely used as a novel carrier for transdermal drug delivery. The Transfersomes can be evaluated by in vitro for vesicle shape and size, entrapment efficiency, degree of deformability, number of vesicles per cubic mm. Transfersomes enhances the penetration of most of the low as well as high molecular weight drugs. When tested in artificial systems transfersomes can pass through even tiny pores (100 nm) which are 1500 times smaller. The use of transfersomes carrier results in delivery of high concentration of active agents through the skin, regulated by system composition and their physical characteristics. Thus, this novel technique has got a great potential for overcoming current problems faced by the conventional techniques.

    (adsbygoogle = window.adsbygoogle || []).push({});
  • PHYSICISTS IN PHARMACEUTICAL INDUSTRY

    ABOUT AUTHOR
    Prakash Chanda Gupta
    Quality Control Executive,
    National Healthcare Pvt. Ltd, Nepal
    p_c_gupta@yahoo.com

    { DOWNLOAD AS PDF }

    ABSTRACT
    The science of physics is understood to be very away from the Pharmaceutical Science. But in the real context, Physics is found to be most densely involved in the Pharmaceutical Science than any other field of science. Physics can be considered as a backbone that supports Pharmaceutical Science. The advance technology that describes that formation and its mode of action to the biological organ is Physics. The structure, action and result of Pharmaceutical material are explained by the theories of Physics.

  • FORMULATION EVALUATION AND OPTIMIZATION OF MEBENDAZOLE COLON TARGETED SUSTAIN RELEASE PELLETS BY EXTRUSION SPHERONIZATION

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Raval Aniket*, Chauhan Sachin P., Sheth A.K, Shah Nirmal, Aundhia Chintan
    Department of Pharmacy, Sumandeep Vidyapeeth University,
    At & Po Pipariya, Ta. - Waghodia, Dist. Vadodara, Gujarat, India
    aniket_raval2006@yahoo.co.in

    ABSTRACT:
    The aim of present investigation is to formulate evaluate and optimization of colon targeted pellets bearing mebendazole, benzimidazole derivative with broad spectrum of anthelminthic activity. It is highly effective against adult and larval stages of ascaris lumbricoids, hook worms and  indicated for the treatment of nematode infestation. Pellets were prepared by extrusion spheronization process using microcrystalline cellulose as spheronizing aid, natural polysaccharide pectin as binders in three different percentages i.e 5%, 10% and 15% and glycerine as plasticizer.  Further study was carried out to select the natural polysaccharide for formulation of colon targeted pellets i.e. Pectine, Xanthan gum and Guar gum. The formulation were prepared with optimized constant process parameters i.e. Percentage LOD 10%, Spheronization time 3 minutes and Speed of spheronization 700-1200 rpm. Prepared A1 – A9 batches were then evaluated by their micromeritic properties like tapped density, carr’s index, hausner, S ratio, angle of repose  and characterized by microscopic study, % yield, hardness, friability, % assay and dissolution study was carried out and compared with marketed formulation by statistical analysis similarity factor (f2). The batch A5 is having 10% pectin, 18% MCC and 20% mebendazole shows (22.20±2.05) % carr’s index, (1.22±0.04) hausner’s ratio, (26.65±1.15) angle of repose, (88.2±2.36) % yield, (3.96±0.46) hardness, (0.23±0.03) % friability  (88.47±3.26) % assay and (99.81±3.80) % drug release after 10 hours. Pellets equivalent to 300mg of mebendazole  were then filled in capsules and capsules coated with 12.5% w/v Eudragit S 100 using optimized 4- 5 ml/min spray rate, 15 rpm pan speed and 40±5°C coating inlet temperature and then optimized for % weight gain in four different trials. W2 batch having 10% weight gain were then evaluated by % cumulative drug release, disintegration test in 0.1 N HCl shows (99.73±3.34) % CDR, intact after 12 hours. The pellets of batch A5 and the enteric coated capsule with 10 % weight gain were packed in aluminum pouch and charged for accelerated stability studies at (40°C±2°C) and (75%±5%) RH for 1 month in a stability chamber shows no change in the dissolution profile at (40°C±2°C) and (75%±5%) RH storage condition.

  • A REVIEW: DETERMINATION OF ITOPRIDE HYDROCHLORIDE IN BIOLOGICAL FLUID AND PHARMACEUTICAL DOSAGE FORMS

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Asif I Bhim*, Vineet Jain, Hasumati Raj
    Shree Dhanvantary Pharmacy College,
    Kim, Gujarat, India
    bhimiqbal23@gmail.com

    ABSTRACT:
    Itopride Hydrochloride is a novel, synthesized, gastro prokinetic drug, which stimulates gastrointestinal motor activity through the synergistic effects of dopamine D2-receptor blockade and acetylcholine esterase inhibitors. Chemically, it is N-[[4-[2-(Dimethyl amino) ethoxy] phenyl] methyl]-3, 4-dimethoxy benzamide hydrochloride. Benzamide structure, amide and ether linkages in the drug molecule make it susceptible to degradation. Thus a prokinetic drug like Itopride Hydrochloride by virtue of its efficacy and tolerability could be considered as a drug of first choice and a welcome addition to the drug armamentarium for the symptomatic treatment of NUD (non-ulcer Dyspepsia) and other gastric motility disorders including functional bowel disorders. This review consists of various analytical methods for determination of Itopride Hydrochloride in various marketed pharmaceutical preparation and in biological fluids. Analytical method consists of various spectroscopic methods, chromatographic methods and other methods.

  • ALTERNATIVES TO THE DRAIZE EYE TEST
  • EDARAVONE: A REVIEW ON ANALYTICAL METHOD AND ITS DETERMINATION IN BIOLOGICAL MATRIX AND SYNTHETIC MIXTURE
Subscribe to Pharmaceutics Articles